ATAI ATAI Life Sciences NV
- Stocks
- Healthcare
- NASDAQ: ATAI
Price (delayed)
$4.48
Market cap
$960.24M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.69
Enterprise value
$907.51M
Relative Growth:
Rel. Growth:
31
Relative Strength:
Rel. Strength:
96
Relative Valuation:
Rel. Valuation:
1
Relative Profitability:
Rel. Profitability:
20
Highlights
The debt has dropped by 65% since the previous quarter and by 53% year-on-year
ATAI Life Sciences's revenue has increased by 24% QoQ
The net income has plunged by 106% YoY but it has grown by 20% from the previous quarter
ATAI's EPS has dropped by 92% year-on-year but it is up by 24% since the previous quarter
ATAI's quick ratio is down by 41% year-on-year
The equity has declined by 14% year-on-year and by 5% since the previous quarter
Key stats
What are the main financial stats of ATAI
Market
Valuations
Earnings
Shares outstanding
214.34M
Market cap
$960.24M
Enterprise value
$907.51M
Price to earnings (P/E)
N/A
Price to book (P/B)
6.24
Price to sales (P/S)
381.38
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
393.03
Revenue
$2.31M
Gross profit
$2.31M
Operating income
-$99.26M
Net income
-$119.4M
EBIT
-$116.63M
EBITDA
-$115.37M
Free cash flow
-$75.97M
Per share
Balance sheet
Liquidity
EPS
-$0.69
EPS diluted
-$0.69
Free cash flow per share
-$0.39
Book value per share
$0.72
Revenue per share
$0.01
TBVPS
$0.94
Total assets
$189.2M
Total liabilities
$45.28M
Debt
$9.22M
Equity
$143.74M
Working capital
$77.13M
Debt to equity
0.06
Current ratio
4.02
Quick ratio
3.76
Net debt/EBITDA
0.46
Margins
Efficiency
Dividend
EBITDA margin
-4,996.4%
Gross margin
100%
Net margin
-5,171.2%
Operating margin
-4,298.9%
Return on assets
-64.4%
Return on equity
-85.6%
Return on invested capital
-83.4%
Return on capital employed
-71.3%
Return on sales
-5,051%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATAI stock price
How has the ATAI Life Sciences stock price performed over time
Intraday
-15.15%
1 week
-23.55%
1 month
-14.34%
1 year
314.81%
YTD
236.84%
QTD
-15.31%
Financial performance
How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$2.31M
Gross profit
$2.31M
Operating income
-$99.26M
Net income
-$119.4M
Gross margin
100%
Net margin
-5,171.2%
The net income has plunged by 106% YoY but it has grown by 20% from the previous quarter
ATAI Life Sciences's operating margin has soared by 85% YoY and by 20% from the previous quarter
The net margin has surged by 66% year-on-year and by 35% since the previous quarter
ATAI Life Sciences's revenue has increased by 24% QoQ
Price vs fundamentals
How does ATAI's price correlate with its fundamentals
Growth
What is ATAI Life Sciences's growth rate over time
Valuation
What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
6.24
P/S
381.38
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
393.03
ATAI's EPS has dropped by 92% year-on-year but it is up by 24% since the previous quarter
The P/B is 184% more than the 5-year quarterly average of 2.2
The equity has declined by 14% year-on-year and by 5% since the previous quarter
ATAI's P/S is 47% below its 5-year quarterly average of 724.7 and 2.8% below its last 4 quarters average of 392.4
ATAI Life Sciences's revenue has increased by 24% QoQ
Efficiency
How efficient is ATAI Life Sciences business performance
ATAI's ROS has soared by 65% year-on-year and by 35% since the previous quarter
ATAI's ROA is up by 17% since the previous quarter
The company's return on equity rose by 16% QoQ
The company's return on invested capital rose by 7% QoQ
Dividends
What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATAI.
Financial health
How did ATAI Life Sciences financials performed over time
ATAI's quick ratio is down by 41% year-on-year
The current ratio has contracted by 40% YoY
The debt is 94% smaller than the equity
The company's debt to equity has shrunk by 67% QoQ and by 50% YoY
The debt has dropped by 65% since the previous quarter and by 53% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.